Features of macro- and microvascular complications in patients with type 2 diabetes mellitus (observational case-control study)

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Diabetic macro- and microvascular complications are the most important chronic complications of type 2 diabetes mellitus (DM2), many features of which require further study. Continued research in this area can help improve the quality of diagnostics of these complications, including at the early stages of their development.

Objective. Evaluation of the features of macro- and microvascular complications in DM2 patients.

Methods. A total of 122 DM2 patients at an average age of 62.3±9.5 years were examined. The control group consisted of 40 practically healthy individuals. All patients underwent standard examinations, including determination of glycated hemoglobin, blood lipids, creatinine, uric acid, insulin, cystatin C levels, daily proteinuria, and urine albumin-creatinine ratio. Neurological status with assessment of pain, tactile, and vibration sensitivity was examined. Echocardiography, ultrasound examination of the brachiocephalic arteries, reactive hyperemia test, and ultrasound of the peroneal nerves (PN) were performed.

Results. The patients included in the study had a fairly long duration of diabetes, were characterized by poor glycemic control, and the presence of multiple vascular risk factors; therefore, most of them developed a wide range of microvascular complications, which were often presented in various combinations. Among these patients, there was a high proportion of individuals with various macrovascular DM2 complications, as well as with associated comorbid conditions. Clinical and laboratory data of diabetic patients were characterized by numerous differences from healthy individuals, including higher levels of blood pressure, glycemia, insulin resistance, lipidemia, uricemia, azotemia, albuminuria; a number of clinical and laboratory features were noted in patients with various microvascular complications of diabetes. DM2 patients demonstrated distinct manifestations of cardiovascular remodeling. Clinical features of diabetic polyneuropathy (DPN) and sonographic characteristics of PN demonstrated a close relationship, which allows to consider PN ultrasound as one of the possible accessible and informative methods for diagnosing (including at early, asymptomatic or low-symptom stages) and predicting the course of DPN in DM2.

Conclusion. The diagnostic approaches used allow to evaluate the features of diabetes-associated microvascular and macrovascular complications at the modern stage, to study their relationships with each other and with the nature of the course of DM2. The close relationships between the sonographic characteristics of PN and the clinical features of DPN established in this work allow to consider PN ultrasound as one of the possible accessible and informative methods for diagnosing DPN in DM2.

Full Text

Restricted Access

About the authors

A. E. Bagriy

M. Gorky Donetsk State Medical University

Author for correspondence.
Email: klassiki@inbox.ru
ORCID iD: 0000-0002-0295-3724
Russian Federation, Donetsk

A. V. Stefanenko

M. Gorky Donetsk State Medical University

Email: klassiki@inbox.ru
ORCID iD: 0009-0009-3597-1812
Russian Federation, Donetsk

E. S. Mikhailichenko

M. Gorky Donetsk State Medical University

Email: klassiki@inbox.ru
ORCID iD: 0000-0001-8625-1406

Cand. Sci. (Med.), Associate Professor

Russian Federation, Donetsk

E. R. Stefanenko

M. Gorky Donetsk State Medical University

Email: klassiki@inbox.ru
ORCID iD: 0000-0003-4074-5309
Russian Federation, Donetsk

Ya. S. Sabelnikova

M. Gorky Donetsk State Medical University

Email: klassiki@inbox.ru
ORCID iD: 0000-0003-2333-8381
Russian Federation, Donetsk

References

  1. Faselis C., Katsimardou A., Imprialos K., et al. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):117–24. doi: 10.2174/1570161117666190502103733.
  2. Ahmad E., Lim S., Lamptey R., et al. Type 2 diabetes. Type 2 diabetes. The Lancet. 2022;400(10365):1803–20. doi: 10.1016/S0140-6736(22)01655-5.
  3. Morcos M., Humpert P., Bierhaus A., et al. The unsolved problem of diabetes mellitus type 2 and associated complications. Der Chirurg. 2009;80:398–409. doi: 10.1007/s00104-008-1630-7.
  4. Borse S.P., Chhipa A.S., Sharma V., et al. Management of type 2 diabetes: current strategies, unfocussed aspects, challenges, and alternatives. Med Princ Pract. 2021;30(2):109–21. doi: 10.1159/000511002.
  5. Narayan S., Goel A., Singh A.K., et al. High resolution ultrasonography of peripheral nerves in diabetic patients to evaluate nerve cross sectional area with clinical profile. Br J Radiol. 2021;94(1121):20200173. doi: 10.1259/bjr.20200173.
  6. Yavuz K., Yurdakul F.G., Guler T., et al. Predictive value of ultrasonography in polyneuropathy diagnosis: electrophysiological and ultrasonographic analysis. Rheumatol Int. 2023;43:1733–42. doi: 10.1007/s00296-023-05356-9.
  7. Wong N.D., Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685–95. doi: 10.1038/s41569-023-00877-z.
  8. Khusainova M.A. Cystatin C is an early marker of decreased kidney function. Oriental renaissance: Innovative, educational, natural and social sciences. 2023:3(1):485–90.
  9. Galicia-Garcia U., Benito-Vicente A., Jebari S., et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275. doi: 10.3390/ijms21176275.
  10. Дедов И.И., Шестакова М.В., Майоров А.Ю. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Сахарный диабет. 2023;26(2S):1–157. [Dedov I.I., Shestakova M.V., Mayorov A.Yu. et al. Algorithms for specialized medical care for patients with diabetes mellitus. Diabetes mellitus. 2023;26(2S):1–157. (In Russ.)].
  11. Zakir M., Ahuja N., Surksha M.A., et al. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023;15(9):e45835. doi: 10.7759/cureus.45835.
  12. Salvatore T., Pafundi P.C., Galiero R., et al. The diabetic cardiomyopathy: the contributing pathophysiological mechanisms. Front Med (Lausanne). 2021;8:695792. doi: 10.3389/fmed.2021.695792.
  13. Hoogeveen E.K. The epidemiology of diabetic kidney disease. Kidney and Dialysis. 2022;2(3):433–42. doi: 10.3390/kidneydial2030038.
  14. Lin K.Y., Hsih W.H., Lin Y.B., et al. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322–25. doi: 10.1111/jdi.13480.
  15. Teo Z.L., Tham Y.C., Yu M., et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–91. doi: 10.1016/j.ophtha.2021.04.027.
  16. Feldman E.L., Callaghan B.C., Pop-Busui R., et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(41):1–18. doi: 10.1038/s41572-019-0092-1.
  17. Ziegler D., Papanas N., Schnell O., et al. Current concepts in the management of diabetic polyneuropathy. J Diabetes Investig. 2021;12(4):464–75. doi: 10.1111/jdi.13401.
  18. Strand N., Anderson M.A., Attanti S., et al. Diabetic Neuropathy: Pathophysiology Review. Curr Pain Headache Rep. 2024;28(6):481–87. doi: 10.1007/s11916-024-01243-5.
  19. Senarai T., Pratipanawatr T., Yurasakpong L., et al. Cross-Sectional Area of the Tibial Nerve in Diabetic Peripheral Neuropathy Patients: A Systematic Review and Meta-Analysis of Ultrasonography Studies. Medicina (Kaunas). 2022;58(12):1696. doi: 10.3390/medicina58121696.
  20. Kelle B., Evran M., Ball T., et al. Diabetic peripheral neuropathy: Correlation between nerve cross-sectional area on ultrasound and clinical features. J Back Musculoskelet Rehabil. 2016;29(4):717–22. doi: 10.3233/BMR-160676.
  21. Huang H., Wu S. Application of high-resolution ultrasound on diagnosing diabetic peripheral neuropathy. Diabetes Metab Syndr Obes. 2021;14:139–52. doi: 10.2147/DMSO.S292991.
  22. Карасева З.В., Аметов А.С., Салтыкова В.Г. и др. Диагностика диабетической полинейропатии при сахарном диабете 2-го типа: фокус на изменениях в периферических нервах по данным ультразвукового метода исследования. Digital Diagnostics. 2024;5(1S):65–7. [Karaseva Z.V., Ametov A.S., Saltykova V.G., et al. Diagnosis of diabetic polyneuropathy in type 2 diabetes mellitus: focus on changes in peripheral nerves according to ultrasound examination data. Digital Diagnostics. 2024;5(1S):65–7. (In Russ.)]. doi: 10.17816/DD626159.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Frequency of occurrence of various macrovascular complications and comorbid conditions among 122 patients with type 2 diabetes, %

Download (56KB)
3. Fig. 2. Characteristics of the distribution of different types of microvascular complications and their combinations in 122 patients with type 2 diabetes, absolute number of patients (% of their total number)

Download (84KB)
4. Fig. 3. The proportion of individuals with various changes in ultrasound examination of the MBN among individuals with and without symptoms of DPN, the absolute number of patients (% of their total number in the group)

Download (111KB)

Copyright (c) 2024 Bionika Media